Articles

Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves

Biogen shares gained ground before market open Wednesday, after the company reported first-quarter profit that beat analysts’ expectations amid improving uptake of its Alzheimer’s treatment.

Hilton’s stock pops after earnings beat estimates, despite the impact of bad weather

Hilton’s stock rose early Wednesday, after the hotel operator’s first-quarter earnings beat estimates, even as the company grappled with bad weather and other issues.

Trump’s immunity case goes to the Supreme Court this week. Here’s why it matters.

The Supreme Court will hear arguments Thursday by Trump lawyers that the former president is constitutionally immune from prosecution on criminal charges that he conspired to overturn the results of the 2020 election.

Tesla’s Musk answers one big question — but introduces many more

Tesla says it’s still focused on a lower-cost car, but UBS thinks many aspects are “still in flux.”

Humana reports big profit beat, predicts growth in Medicare Advantage membership

The company said the big earnings beat was mostly driven by lower-than-planned administrative expenses.

How to empower your kids through financial literacy

Creating a ‘household economy’ taught our kids about money and life

‘Irrational excitement’ over AI will wipe out tech stocks, says contrarian investor who has nailed prior selloffs

Steven Jon Kaplan, author of the True Contrarian blog and newsletter, says a popular tech ETF is headed for hard times thanks to “irrational” AI excitement.

Boston Scientific’s stock jumps premarket as earnings shine and company offers upbeat guidance

Sales of cardiovascular products rose 15.9% in the quarter, helping the company beat estimates.

Why do some people have a will but others don’t?

Without a will, asset dispersal can be problematic

Stock-market pessimism is climbing. Why it’s still not bad enough to imply stocks hit a bottom.

Stocks could have more room to fall before they touch bottom, says Tom Essaye, founder of Sevens Report Research.

Home buyers turn to adjustable-rate mortgages as 30-year rate zooms past 7%

Mortgage applications fell 2.7% in the last week, the Mortgage Bankers Association said. The average rate for a 30-year mortgage stood at 7.24%.

Roche prepares for business after boom from COVID-related products

The Swiss pharmaceutical company reiterated its outlook, predicting single-digit growth this year, following an end to the slump in COVID-19-related sales.
1 1,325 1,326 1,327 1,328 1,329 2,403